ArticleProceedings of the National Academy of Sciences of the United States of America2015

Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma.

Fabienne Guillaumond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.